Synlogic therapeutics stock
WebOperating Status Closed. Last Funding Type Post-IPO Equity. Legal Name Mirna Therapeutics, Inc. Stock Symbol NASDAQ:MIRN. Company Type For Profit. Contact Email [email protected]. Phone Number 5126815201. Mirna Therapeutics, Inc. (Mirna) is a discovery-stage biopharmaceutical research and development company focused on … WebName. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ...
Synlogic therapeutics stock
Did you know?
WebAug 28, 2024 · CAMBRIDGE, Mass. & AUSTIN, Texas -- (BUSINESS WIRE)--Aug. 28, 2024-- Synlogic, Inc. and Mirna Therapeutics, Inc. today announced that the proposed merger of …
WebJan 31, 2024 · The story starts with a startup called Mirna Therapeutics that had raised $110 million from big name investors like New Enterprise Associates, Pfizer, and Baxter to pursue an RNAi drug development platform they had been working on since 2007.In October of 2015, Mirna had an IPO which has since lost more than -80% of its value. Mirna was a … WebJan 19, 2024 · Continue Reading. October 18, 2024. Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3. Continue …
WebSynlogic, Inc. (SYBX) delivered earnings and revenue surprises of 7.69% and 73.50%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? Discover historical prices for SYBX stock on Yahoo Finance. View daily, weekly or … Find the latest Synlogic, Inc. (SYBX) stock discussion in Yahoo Finance's forum. … View the basic SYBX option chain and compare options of Synlogic, Inc. on … Synlogic, Inc. 301 Binney Street Suite 402 Cambridge, MA 02142 United States 617 … See Synlogic, Inc. (SYBX) Environment, Social and Governance Ratings to help … Find out the direct holders, institutional holders and mutual fund holders for … Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 7.69% and 73.50%, … See Synlogic, Inc. (SYBX) stock analyst estimates, including earnings and … WebMr. Jensen was formerly the CFO of Intrinsic Therapeutics. Fourth Quarter 2024 Financial Results. As of December 31, 2024, Synlogic had cash, cash equivalents, and marketable …
WebMar 28, 2024 · Synlogic is the leading company advancing therapeutics based on synthetic biology. Synlogic’s pipeline includes its lead program in phenylketonuria (PKU), which has demonstrated proof of concept with plans to start a pivotal, Phase 3 study in the first half of 2024, and additional novel drug candidates designed to treat homocystinuria (HCU), …
WebAug 11, 2024 · Three clinical data readouts across three programs expected in H2 2024 – – PKU Phase 3 readiness activities underway for planned start in H1 2024 – – $106.8 million in cash, cash equivalents and short-term investments support projected runway into 2024 – – Conference call and webcast at 8:30 a.m. ET today – CAMBRIDGE, Mass., Aug. 11, 2024 … key lime crunch cakeWebMar 3, 2024 · Prior to joining Synlogic, Mr. Jensen was the CFO at Intrinsic Therapeutics, a commercial-stage medical device company focused on delivering treatments to improve surgical efficacy. Prior to Intrinsic, Mr. Jensen held financial leadership roles at several biotech and healthcare companies including Taconic Biosciences, Straumann North … key lime cupcakes using cake mixWebName. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and … keylime cove waterpark resort gurnee il